Creotech Instruments (CRI) Q2 2024 earnings summary

Executive summary

• Revenue for H1 2024 was 17.1m PLN, down 2.7m PLN year-over-year, mainly due to lower grant income.

• Net loss for H1 2024 was 7.5m PLN, compared to a net loss of 5.7m PLN in H1 2023.

• Key projects progressed, including the successful launch of the EagleEye satellite and new ESA contracts.

• The company continues to focus on R&D and expanding its product portfolio in space and drone technologies.

Financial highlights

• Revenue from product sales: 11.8m PLN (flat year-over-year); grant income: 5.3m PLN (down from 8.0m PLN).

• Operating loss: 9.1m PLN (vs. 6.7m PLN loss in H1 2023).

• Net cash outflow from operations: 1.9m PLN; total cash at period end: 59.8m PLN.

• Total assets: 165.3m PLN (down 7.2m PLN from year-end 2023); equity: 83.8m PLN.

• No dividend paid in the period.

Outlook and guidance

• The company expects future results to be influenced by the timing of project milestones and component availability.

• Ongoing R&D intensity and project phase transitions will impact short-term profitability.

• New ESA contracts and recommended grant projects are expected to support future growth.